Patient Outcomes Summary:
Autologous Cellular Treatment Therapy & its Effects on COPD

Ongoing Results Case Study for COPD Patients Treated by the Lung Institute | Jack Coleman Jr., M.D. Today more than 600 million people suffer from chronic obstructive pulmonary disease (COPD) worldwide. Although there is no cure for COPD, recent advancements in cellular therapy have made it possible not only to relieve symptoms but to promote…

Read More >

Autologous Cellular Therapy and its Effects on COPD:
A Pilot Study

Author: Jack Coleman Jr., M.D. Today more than 600 million people suffer from chronic obstructive pulmonary disease (COPD) worldwide. Although there is no cure for COPD, recent advancements in cellular therapy have made it possible not only to relieve symptoms, but to promote healing within the lungs themselves. After testing approximately 100 patients, the Lung…

Read More >

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.